Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Fowler

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2016
Frontline strategy for follicular lymphoma: are we ready to abandon chemotherapy?Nathan Fowler
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Developing novel strategies to target B-cell malignanciesNathan Fowler, Yasuhiro Oki
Hematology. American Society of Hematology. Education Program|December 10, 2013
Targeting B-cell receptor signaling: changing the paradigmNathan Fowler, Eric Davis
Clinical Journal of Oncology Nursing|March 19, 2017
Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm
Haleigh Mistry, Sheryl G Forbes, Nathan Fowler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin LymphomaJohn G Gribben, Nathan Fowler, Franck Morschhauser
Leukemia & Lymphoma|May 7, 2010
Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experienceAli Mazloom, Nathan Fowler, L Jeffrey Medeiros, et al.
Cancer|September 20, 2013
Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphomaAli Mazloom, Alma Rodriguez, Chul S Ha, et al.
American Journal of Clinical Oncology|January 7, 2014
Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution ExperienceMichelle M Kim, Bouthaina S Dabaja, Jeffrey Medeiros, et al.
Annals of Hematology|January 30, 2015
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphomaMyron S Czuczman, Stephen Kahanic, Andres Forero, et al.
Cancer Causes & Control : CCC|March 6, 2009
Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypesLenka Goldman, Sameera Ezzat, Nadia Mokhtar, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Hematology. American Society of Hematology. Education Program|December 4, 2016
Frontline strategy for follicular lymphoma: are we ready to abandon chemotherapy?Nathan Fowler
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Developing novel strategies to target B-cell malignanciesNathan Fowler, Yasuhiro Oki
Hematology. American Society of Hematology. Education Program|December 10, 2013
Targeting B-cell receptor signaling: changing the paradigmNathan Fowler, Eric Davis
Clinical Journal of Oncology Nursing|March 19, 2017
Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm
Haleigh Mistry, Sheryl G Forbes, Nathan Fowler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2015
Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin LymphomaJohn G Gribben, Nathan Fowler, Franck Morschhauser
Leukemia & Lymphoma|May 7, 2010
Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experienceAli Mazloom, Nathan Fowler, L Jeffrey Medeiros, et al.
Cancer|September 20, 2013
Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphomaAli Mazloom, Alma Rodriguez, Chul S Ha, et al.
American Journal of Clinical Oncology|January 7, 2014
Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution ExperienceMichelle M Kim, Bouthaina S Dabaja, Jeffrey Medeiros, et al.
Annals of Hematology|January 30, 2015
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphomaMyron S Czuczman, Stephen Kahanic, Andres Forero, et al.
Cancer Causes & Control : CCC|March 6, 2009
Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypesLenka Goldman, Sameera Ezzat, Nadia Mokhtar, et al.
Pageof 9